Elmiron Alternatives Compared
Elmiron (pentosan polysulfate sodium) | Phenazopyridine | Amitriptyline |
|
---|
Elmiron (pentosan polysulfate sodium) | Phenazopyridine | Amitriptyline |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Interstitial Cystitis, Bladder Infection. Elmiron may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Interstitial Cystitis, Dysuria. Phenazopyridine may also be used for purposes not listed in this medication guide. |
Prescription only
Amitriptyline is an effective antidepressant but it may cause drowsiness initially and a withdrawal syndrome with abrupt discontinuation. It may be used off-label to treat other conditions such as... View more |
Related suggestions Interstitial Cystitis
Popular comparisons
|
|||||||||||||||||||||||
More about Elmiron (pentosan polysulfate sodium) | More about Phenazopyridine | More about Amitriptyline | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Elmiron has an average rating of 7.2 out of 10 from a total of 107 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 22% reported a negative effect. |
Phenazopyridine has an average rating of 6.9 out of 10 from a total of 190 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 27% reported a negative effect. |
Amitriptyline has an average rating of 7.6 out of 10 from a total of 1812 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Elmiron side effects |
View all Phenazopyridine side effects |
View all Amitriptyline side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Elmiron prices |
View all Phenazopyridine prices |
View all Amitriptyline prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Azo Urinary Pain Relief, Azo-Gesic, Azo-Septic, Azo-Standard, Baridium, Eridium, Preferred Maximum Strength Urinary Pain Relief, Preferred Urinary Pain Relief, Prodium, Pyridium, Re-Azo, Uricalm, Uristat, Uristat Ultra, Uro-Pain View more |
N/A |
||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
4.8 hours |
N/A |
16 hours |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 80 drugs are known to interact with Elmiron:
|
A total of 60 drugs are known to interact with Phenazopyridine:
|
A total of 718 drugs are known to interact with Amitriptyline:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
September 26, 1996 |
N/A |
April 07, 1961 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.